中国发展网讯记者高杨报道12月9日，记者从山东省政府新闻办举行的介绍山东国有企业高标准履行社 会责任服务经济社会发展情况新闻发布会上获悉，近年来，山东省国资委坚决贯彻落实省委、省政府关 于加快建设绿色低碳高质量发展先行区的决策部署，督促指导省属企业扛牢重大使命，狠抓工作落实， 推动绿色低碳高质量发展取得积极成效。今年，省属企业共有14个项目入选省绿色低碳高质量发展重点 项目，截至10月末已完成投资32.43亿元。 坚持高位推动，政策支持更加有力。召开省属企业科技创新、生态环保工作会议，出台《关于省属企业 加快发展新质生产力的实施意见》《关于深入推进省属企业科技创新工作提质增效的实施方案》等一系 列支持政策，指导9户重点用能企业编制碳达峰工作方案，推动省属企业降碳减污扩绿增长。2024年， 省属企业环境保护及生态恢复支出67.3亿元，主要用能企业能源消耗总量同比下降4.8%、二氧化碳排放 量同比下降2%。 狠抓科技创新，发展动能更加澎湃。将科技创新作为推动绿色低碳高质量发展的重要引擎，推动省属企 业加快培育培强战略性新兴产业。1—10月份，省属企业战略性新兴产业实现营业收入5346.03亿元、同 比增长42.6 ...

齐鲁晚报.齐鲁壹点记者李殷婷 坚持高位推动，政策支持更加有力。召开省属企业科技创新、生态环保工作会议，出台《关于省属企业加快发展新质生产力的实施意见》《关于深入推进 省属企业科技创新工作提质增效的实施方案》等一系列支持政策，指导9户重点用能企业编制碳达峰工作方案，推动省属企业降碳减污扩绿增长。2024 年，省属企业环境保护及生态恢复支出67.3亿元，主要用能企业能源消耗总量同比下降4.8%、二氧化碳排放量同比下降2%。 狠抓科技创新，发展动能更加澎湃。将科技创新作为推动绿色低碳高质量发展的重要引擎，推动省属企业加快培育培强战略性新兴产业。1-10月份，省属 企业战略性新兴产业实现营业收入5346.03亿元、同比增长42.65%。加快推动数字化转型，指导企业积极建设产业大脑、数字化车间、智能工厂、工业互 联网平台，13户企业获批工信部第一批卓越级智能工厂。浪潮集团打造了国内首个实体化的人工智能工厂，实现人工智能应用的集约高效量产。山东能源 联合华为公司发布全球首个矿山领域商用人工智能大模型"盘古矿山大模型"，实现矿山领域人工智能模型的规模化复制和快速应用推广。山东港口建成全 国首个全国产全自主自动化集装箱码头， ...

Core Viewpoint - The traditional dye industry is shifting from chemical indigo to bio-synthesized indigo, addressing environmental and safety concerns associated with chemical production [1][4]. Group 1: Industry Dynamics - Chemical indigo production poses significant environmental risks due to toxic wastewater emissions, which can severely pollute soil and water if not properly treated [1]. - The bio-synthesis of indigo is emerging as a sustainable alternative, with a strategic partnership formed between the Shenzhen Institute of Advanced Technology and DaoSheng Biotechnology to develop natural colorants and pharmaceuticals [1][2]. Group 2: Company Development - DaoSheng Biotechnology was founded by Yuan Xiaoli, who transitioned from agricultural projects to bio-synthesis for natural color extraction, establishing the company in Shenzhen to leverage local industry opportunities [2][3]. - The company has successfully achieved mass production of bio-indigo, with a production capacity exceeding 72 tons of plant-derived indigo in just three days, representing a more than 100-fold increase in efficiency compared to traditional methods [4]. Group 3: Technological Advancements - The collaboration between Shenzhen Institute and DaoSheng focuses on utilizing synthetic biology techniques to enhance the production of various natural colorants, including black pigment, which is in high demand in the textile and dyeing industries [3][5]. - The innovative joint team aims to achieve a black pigment production target of 5 grams per liter by the end of the year, with plans to scale up to 10 grams per liter in the following year [6]. Group 4: Market Potential - The synthetic biology industry is projected to reach nearly $50 billion by 2028, indicating significant growth potential and diverse applications across pharmaceuticals, cosmetics, and food industries [6][7]. - The development of black pigment could lead to substantial economic value, with applications such as natural UV protection in sunscreens and targeted drug delivery systems in cancer treatment [6].

Core Viewpoint - Zhong Shanshan will hold 10.58% of Jinbo Biological's shares following a strategic investment agreement, marking a significant shift in the company's ownership structure and potential for future growth [2][4]. Group 1: Shareholding Changes - On June 26, Jinbo Biological announced that its controlling shareholder, Yang Xia, signed a share transfer agreement with Hangzhou Jiushi, transferring 5% of the company's total shares for a price of 243.84 RMB per share, totaling 1.403 billion RMB [4]. - Following the equity changes, Yang Xia will hold 50.73% of Jinbo Biological, while Hangzhou Jiushi and Yangsheng Tang will hold 4.71% and 5.87% respectively [5]. Group 2: Financing and Investment - Jinbo Biological plans to raise up to 2 billion RMB through a private placement of shares to Yangsheng Tang, which will account for 6.24% of the company's total shares prior to the issuance [4][5]. - This financing round, if successful, will become the largest cash private placement in the history of the Beijing Stock Exchange [2]. Group 3: Strategic Development - The core focus of the raised funds will be the development of a humanized collagen FAST database and product development platform, aimed at enhancing the company's product offerings in wound care, orthopedic implants, hair health, and ophthalmic drugs [7]. - The collaboration with Yangsheng Tang is expected to leverage both companies' strengths, enhancing market competitiveness and accelerating industrialization and commercialization capabilities [7].

Core Viewpoint - The article discusses the strategic investment by Zhong Shanshan, who will hold 10.58% of Jinbo Biological after a recent share transfer and subscription agreement, marking a significant development for the company and the North Exchange market [2][5]. Group 1: Share Transfer and Investment Details - On June 26, Jinbo Biological announced that its controlling shareholder, Yang Xia, signed a share transfer agreement with Hangzhou Jiushi, transferring 5% of the company's total shares at a price of 243.84 RMB per share, totaling 1.403 billion RMB [3][4]. - Jinbo Biological will issue shares equivalent to 6.24% of its total shares to Yang Xia's strategic investor, Yangsheng Tang, with a financing amount not exceeding 2 billion RMB [3][4]. Group 2: Ownership Structure Post-Transaction - After the equity change, Yang Xia will hold 50.73% of Jinbo Biological, while Hangzhou Jiushi and Yangsheng Tang will hold 4.71% and 5.87% respectively [4][5]. - Yangsheng Tang, controlled by Zhong Shanshan, also holds significant stakes in other companies, including 66.88% of Nongfu Spring and 55.79% of Wantai Biological [4]. Group 3: Strategic Focus and Future Plans - The core focus of the fundraising is the development of a humanized collagen FAST database and product development platform, which aims to enhance Jinbo Biological's product offerings in various medical fields [7]. - The integration of AI design parameters with industrial production processes is expected to accelerate the transformation of research outcomes into market-ready products, creating a "data + algorithm" competitive advantage [7]. - The collaboration with Yangsheng Tang is anticipated to leverage both companies' strengths, enhancing market capabilities and accelerating technological development [7].